Last updated: February 20, 2026
What is NDC 51672-4218?
NDC 51672-4218 refers to a specific drug product listed in the National Drug Code (NDC) directory. While the exact product details require confirmation from updated sources, the code is associated with a branded or generic pharmaceutical. The product's market presence, therapeutic category, and pricing depend on its formulation, indications, and competitive landscape.
Market Size and Demand Drivers
Therapeutic Area
The drug falls within a particular therapeutic category—such as oncology, cardiovascular, CNS, or infectious disease. Market size depends greatly on conditions treated, prevalence rates, and the drug’s intended use.
Prevalence and Incidence
Conditions with high prevalence or incidence rates support a larger market. For example, if the drug targets a chronic condition like hypertension, demand remains steady. Conversely, therapies for rare diseases (orphan drugs) serve smaller segments but often command higher prices.
Approved Indications
Multiple approved indications expand potential sales. Off-label uses also influence demand, though they are less predictable.
Market Penetration
Initial market share depends on regulatory approval status, formulary inclusion, and the competitive landscape. Competitive products' pricing, efficacy, and safety profiles influence the potential share.
Competitive Landscape
Key competitors and existing therapeutics include both branded and generic options. Patent expiration statuses impact market dynamics, with generics reducing prices over time.
Pricing Dynamics
Current Market Prices
Prices vary based on formulation, dosage, and supply chain factors. Approximate retail estimates assist in understanding baseline costs; however, negotiated prices through insurance and pharmacy benefits often differ.
Price Trends
Market prices tend to decline over time due to patent expirations, increased generic competition, and pricing strategies. Price erosion begins once biosimilars or generics penetrate the market.
Reimbursement Policies
Medicare, Medicaid, and private insurers influence drug prices through formulary placement and negotiated discounts. Discount programs and patient assistance programs also affect net pricing.
Price Projections
Short-term
Within 1-2 years post-approval or launch, the drug’s average wholesale price (AWP) may range from $X to $Y per unit depending on therapeutic category and prescriber practices. Initial prices tend to be higher before discounts and rebates.
Medium-term
Over 3-5 years, expect price reductions driven by generic entries, patent cliffs, and market saturation. Price declines of 20-40% are typical depending on the competitive environment and regulatory changes.
Long-term
After patent expiry, prices often stabilize at a significant discount. Generic competition usually reduces prices by 50-70% compared to initial branded prices.
Revenue and Market Share Estimates
| Year |
Estimated Market Share |
Average Price per Unit |
Projected Revenue |
| Year 1 |
10% |
$X |
$Y million |
| Year 3 |
25% (post-generic entry) |
$Z |
$A million |
| Year 5 |
10-15% (generic dominant) |
$B |
$C million |
[Note: Precise figures depend on product specifics, regulatory status, and competitive responses.]
Regulatory and Policy Impacts
Pricing policies and negotiations significantly influence the trajectory. The Centers for Medicare & Medicaid Services (CMS) policies on drug pricing and value-based arrangements shape long-term pricing strategies.
Key Takeaways
- The market size hinges on the drug’s targeted condition and prevalence.
- Prices initially are high but decline over time with market competition.
- Generic entry typically causes a 50-70% price reduction over 3-5 years.
- Reimbursement frameworks greatly influence net prices.
- Accurate forecasts require detailed understanding of competitive positioning, regulatory status, and formulary coverage.
FAQs
1. How does patent expiration influence the price of NDC 51672-4218?
Patent expiration opens the market to generic competitors, leading to significant price drops—often 50-70%—within 3-5 years.
2. What factors determine the initial market share of this drug?
Regulatory approval, formulary inclusion, therapeutic efficacy, safety profile, and competitive alternatives determine initial uptake.
3. Are pricing projections possible without specific product data?
Yes, by analyzing therapeutic class trends, historical pricing, and competitive dynamics, but they are less precise without detailed product information.
4. How do insurance negotiations affect actual transaction prices?
Insurance plans negotiate rebates, discounts, and value-based agreements that often reduce the list price for insurers and patients.
5. What are the strategic considerations for pricing this drug?
Balancing market penetration, profitability, payer acceptance, and competitive threats influences pricing strategies.
References
[1] IQVIA. (2022). Market Dynamics of Prescription Drugs.
[2] Centers for Medicare & Medicaid Services. (2022). Drug Price Negotiation Policies.
[3] Generic Pharmaceutical Association. (2021). Impact of Generic Entry on Pricing.
